Druggio Logo

Druggio

Glycogen storage disease type II, Pompe disease

Glycogen storage disease type II (GSDII), also known as Pompe disease, is an autosomal recessive lysosomal storage disease caused by a deficiency of acid alpha-glucosidase (GAA). This deficiency results in glycogen accumulation in the lysosomes, leading to lysosomal swelling, cellular damage and organ dysfunction.

Drugs that treat Glycogen storage disease type II, Pompe disease

Nexviazyme

Made by

Sanofi

Approval date

2021/9/27

Myozyme

Made by

Sanofi

Approval date

2007/4/18